Figure 1.

This graph illustrates the estimated GFR versus time (in months) prior to and after completion of the 6-month FONT Treatment Period in patients assigned to rosiglitazone.

Peyser et al. BMC Nephrology 2010 11:2   doi:10.1186/1471-2369-11-2
Download authors' original image